Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Vaccine ; 28(36): 5768-73, 2010 Aug 16.
Article in English | MEDLINE | ID: mdl-20609397

ABSTRACT

Haemophilus ducreyi causes genital ulceration (chancroid), a sexually transmitted infection and still an important factor which contributes to the spread of HIV in developing countries. The bacterium produces a cytolethal distending toxin (HdCDT) causing cell cycle arrest and apoptosis/necrosis of human cells and contributes to the aggravation of ulcers. The aim of the study was to induce toxin-neutralizing antibodies in the genital tract of mice. Repeated subcutaneous (sc) immunisations with 5-10microg active HdCDT induced low levels of serum anti-HdCDT IgG without neutralizing capacity. High levels of specific IgG1 antibodies in serum and genital tract were generated after sc immunisations with 10microg formaldehyde detoxified HdCDT toxoid alone and the addition of aluminium salts or RIBI (based on the lipid A moiety) as adjuvant further increased the level of serum antibodies. A high correlation was found between elevated levels of anti-HdCDT IgG in sera, the level of neutralizing activity and the antibody level in genital tract (r=0.8). Thus, induction of high antibody levels specific to HdCDT in the genital tissue can be achieved by parenteral immunisation with the toxoid. The HdCDT toxoid can be considered as a candidate component in vaccine against chancroid.


Subject(s)
Antibodies, Bacterial/immunology , Antibodies, Neutralizing/immunology , Bacterial Toxins/immunology , Genitalia, Female/immunology , Haemophilus ducreyi/immunology , Animals , Antibodies, Bacterial/blood , Antibodies, Neutralizing/blood , Antibody Formation , Antibody Specificity , Bacterial Vaccines/immunology , Cell Line , Female , Humans , Immunity, Mucosal , Immunoglobulin G/blood , Immunoglobulin G/immunology , Mice , Mice, Inbred BALB C
2.
APMIS ; 118(2): 143-9, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20132178

ABSTRACT

The Haemophilus ducreyi cytolethal distending toxin (HdCDT) catalytic subunit CdtB has DNase-like activity and mediates DNA damage after its delivery into target cells. We constructed a replication-deficient adenovirus type 5 (Ad5) vector expressing CdtB and investigated the toxic properties of this vector on HeLa cells. Ad5CdtB caused loss of cell viability, morphologic changes, and cell cycle arrest, findings similar to HdCDT intoxication. This confirmed that CdtB is responsible for the toxicity of the holotoxin when expressed in cells following transduction by an adenoviral vector, and indicated a possible potential of this novel strategy in studies of activity of intracellular products and in gene therapy of cancer.


Subject(s)
Adenoviridae/genetics , Bacterial Toxins/toxicity , Genetic Vectors , Haemophilus ducreyi/pathogenicity , Bacterial Toxins/genetics , HeLa Cells , Humans
3.
Microbes Infect ; 11(3): 352-60, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19397884

ABSTRACT

Haemophilus ducreyi, the chancroid-causing bacterium, produces lipooligosaccharides (HdLOS) that comprise 5-11 partially sialylated monosaccharides. Subcutaneous immunisation of mice with 5 microg of HdLOS purified from H. ducreyi strains 4438 and 7470 induced high levels of anti-HdLOS IgG. The antibody responses displayed T-cell-independent features, and were dependent upon Toll-like receptor 4/MyD88 signalling pathways as demonstrated using knockout mice. The immunogenicity of HdLOS was found to require the intact lipid A moiety. The specificity studies of the anti-HdLOS antibodies, as revealed by absorption studies, antibody detection in ELISA, and immune thin-layer chromatography, indicated that the majority of the anti-LOS antibodies were specific for the inner core of the HdLOS. Antibodies to HdLOS failed to inhibit LOS induction of TNF-alpha release from human mononuclear cells. The adjuvanticity of HdLOS7470 was assessed in BALB/c mice that were immunised with bovine serum albumin (BSA) with or without the addition of HdLOS. The addition of 5 microg HdLOS resulted in a 10-fold increase in the total anti-BSA IgG antibody level as estimated by ELISA. The highest increase was noted for IgG2b, which contrasted with the predominantly IgG1 subclass response to immunisation with BSA alone, indicating an immunomodulatory activity of the HdLOS.


Subject(s)
Adjuvants, Immunologic/pharmacology , Haemophilus ducreyi/immunology , Lipopolysaccharides/immunology , Lipopolysaccharides/pharmacology , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/isolation & purification , Animals , Antibodies, Bacterial/blood , Cells, Cultured , Haemophilus ducreyi/chemistry , Humans , Immunoglobulin G/blood , Injections, Subcutaneous , Leukocytes, Mononuclear/immunology , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/isolation & purification , Mice , Mice, Inbred BALB C , Mice, Knockout , Myeloid Differentiation Factor 88/immunology , Serum Albumin, Bovine/immunology , Toll-Like Receptor 4/immunology , Tumor Necrosis Factor-alpha/metabolism
4.
Vaccine ; 25(18): 3606-14, 2007 May 04.
Article in English | MEDLINE | ID: mdl-17289219

ABSTRACT

Haemophilus ducreyi cytolethal distending toxin (HdCDT) is a tripartite AB toxin, which causes DNA damage in affected cells. We investigated the effects of formaldehyde on the chemical, biological, and immunological properties of the HdCDT complex, which was purified by immobilizing the glutathione S-transferase (GST)-CdtB fusion protein, followed by binding of the CdtA and CdtC recombinant proteins. The HdCDT was treated with increasing concentrations of formaldehyde in the presence of lysine. The treatment of HdCDT at 1 and 0.1 mg protein/ml with 320 and 80 mM of formaldehyde, respectively, resulted in the complete abrogation of cytotoxic activity, loss of DNase activity, and loss of binding capacity to HeLa cells. The toxoid showed protein bands of 75-150 kDa in SDS-PAGE, composed of the three cross-linked CDT components detected by immunoblotting. Three doses of 10 microg protein/mouse of the formaldehyde-treated HdCDT elicited toxin-neutralizing antibodies at titers about 200 times higher than those elicited by the native toxin. The described methodology may be applied to produce immunogenic toxoids from other CDTs, which might be used as candidate components in vaccines against CDT-producing bacteria, including H. ducreyi.


Subject(s)
Bacterial Toxins/immunology , Bacterial Toxins/toxicity , Formaldehyde/pharmacology , Haemophilus ducreyi/immunology , Toxoids/administration & dosage , Toxoids/immunology , Animals , Antibodies, Bacterial/blood , Bacterial Toxins/administration & dosage , Bacterial Toxins/isolation & purification , Chancroid/prevention & control , Haemophilus Vaccines , Haemophilus ducreyi/growth & development , HeLa Cells , Humans , Immunization , Mice , Mice, Inbred BALB C , Neutralization Tests
5.
Microbes Infect ; 7(5-6): 867-74, 2005 May.
Article in English | MEDLINE | ID: mdl-15876546

ABSTRACT

Haemophilus ducreyi, the etiologic agent of the sexually transmitted disease chancroid, produces a cytolethal distending toxin (HdCDT) that inhibits cultured cell proliferation, leading to cell death. A rabbit model of dermal infection was used to investigate the roles of H. ducreyi bacteria and HdCDT in the development, clinical appearance, and persistence of infection. A non-toxin producing H. ducreyi strain, and for comparison purposes a non-capsulated Haemophilus influenzae strain, were inoculated intradermally, with and without co-administration of purified HdCDT. Co-administration of HdCDT resulted in significant aggravation of H. ducreyi-induced inflammatory lesions, and development of ulcers in rabbit skin. Less pronounced inflammatory lesions and lack of epithelial eruption were observed after inoculation with H. influenzae. Histopathological sections of the H. ducreyi-induced lesions, in both the presence and absence of HdCDT, showed dense infiltrates of the same type inflammatory cells, with the exception of a prominent endothelial cell proliferation noted in sections from lesions caused by H. ducreyi and toxin. Signs of chronic inflammation with involvement of T cells, macrophages, eosinophils, and granuloma formation were observed after H. ducreyi inoculation both with and without toxin. In conclusion, H. ducreyi causes a pronounced, chronic inflammation with involvement of T cells and macrophages, and in combination with HdCDT production of ulcers in the rabbit model. These pathogenic mechanisms may promote the development and persistence of chancroid ulcers.


Subject(s)
Bacterial Toxins/toxicity , Chancroid/pathology , Haemophilus ducreyi/pathogenicity , Animals , Haemophilus Infections/pathology , Haemophilus influenzae , Rabbits , Skin/pathology
6.
Toxicon ; 45(6): 767-76, 2005 May.
Article in English | MEDLINE | ID: mdl-15804526

ABSTRACT

We investigated the impact of highly purified Haemophilus ducreyi cytolethal distending toxin (HdCDT) on the apoptosis and necrosis of various human cells; including myeloid cells, epithelial cells, keratinocytes, and primary fibroblasts. The levels of apoptosis and necrosis induced in these cells were compared to those induced by HdCDT in human T cells and in the Jurkat T cell line. Levels of caspase-3 activity were measured, and membrane changes like phosphatidylserine (PS) translocation was evaluated after double-staining with the fluorescein isothiocyanate (FITC)-labeled annexin V and propidium iodide (PI) using flow cytometry. HdCDT induced various degrees of apoptosis and necrosis in dose- and time-dependent manners in cells of various lineages. Early and late apoptosis (annexin V-stained cells) were induced in more than 90% of T cells and monocytes after treatment with 100 ng/ml HdCDT for 24 and 48 h, respectively. The corresponding numbers for epithelial cells, keratinocytes, and fibroblasts were 26-32% after treatment with 100 ng/ml HdCDT for 48 h. HdCDT appears to eliminate effectively by inducing apoptosis those cells that are involved in immune responses. Epithelial cells, keratinocytes and fibroblasts, which are important for the healing of chancroid ulcers, are eliminated by apoptosis or necrosis after contact with HdCDT, albeit slower and to a lesser extent than T cells.


Subject(s)
Apoptosis/drug effects , Bacterial Toxins/toxicity , Haemophilus ducreyi/chemistry , Annexin A5 , Caspase 3 , Caspases/metabolism , Cell Line, Tumor , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Fibroblasts/drug effects , Flow Cytometry , Humans , Keratinocytes/drug effects , Myeloid Cells/drug effects , Necrosis , Phosphatidylserines/metabolism , Propidium , Protein Transport/drug effects , Statistics, Nonparametric
7.
Microb Pathog ; 35(3): 133-7, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12927521

ABSTRACT

Antibodies specific for the cytolethal-distending toxin of Haemophilus ducreyi (HdCDT) complex and for the CdtA, CdtB, and CdtC components were measured by ELISA in the sera of 50 patients with culture and/or PCR proven chancroid, 42 patients with periodontitis, 50 blood donors from Tanzania, 50 blood donors from Sweden. In addition, the biological activity e.g. neutralization capacity of the sera were tested. Our results demonstrate that majority of chancroid patients and healthy individuals had detectable levels of serum antibodies to HdCDT complex and to separate toxin components. However, high levels (> or =100 units) of antibodies to HdCDT complex were significantly more prevalent in the sera of patients with both chancroid and periodontitis than in the sera of the corresponding controls (P=0.001 and P=0.04, respectively). In the sera of the 50 patients with chancroid, antibodies to CdtA, CdtB, and CdtC were detected in 50, 35, and 34 individuals, respectively. Antibodies to CdtC, being less frequently detected than the antibodies to other components, show a good correlation with the neutralizing capacity of sera. High levels of neutralizing antibodies (> or =160) were detected in only 22 and 2% of the patients with chancroid and periodontitis, respectively. The data suggest that the low levels of anti-HdCDT antibodies, which include neutralizing antibodies, may contribute to limited protection in chancroid and since anti-HdCDT antibodies, may be detected in healthy individuals and in patients with certain disease conditions (e.g. periodontitis), they may not be specific markers for chancroid infection.


Subject(s)
Antibodies, Bacterial/blood , Bacterial Toxins/immunology , Chancroid/immunology , Haemophilus ducreyi/immunology , Aggregatibacter actinomycetemcomitans/immunology , Antibody Specificity , Chancroid/diagnosis , Humans , Periodontitis/immunology
8.
Sex Transm Dis ; 30(2): 114-9, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12567167

ABSTRACT

BACKGROUND: The etiological agent is usually not established in cases of genital ulcer disease (GUD) in Tanzania, since diagnosis and treatment of this disease are based mainly on clinical rather than microbiologic parameters. GUD increases the risk of infection with HIV. However, the association between specific GUD infections and HIV infection has not been fully investigated. GOAL: The goal was to determine the etiology of GUD and the prevalence of HIV infection in patients with GUD in urban areas of Tanzania. STUDY DESIGN: A total of 102 clinical specimens were collected from 52 and 50 patients with GUD in Dar es Salaam and Mbeya, respectively, and from 93 patients with genital discharge in a cross-sectional study. Two polymerase chain reaction (PCR) assays were used to identify either a single target DNA or all three DNAs of the major causes of GUD: Haemophilus ducreyi, Treponema palladum and herpes simplex virus type 2 (HSV-2). The sera from all patients were tested for antibodies to HIV and T palladum. RESULTS: In Dar es Salaam, DNA from HSV-2, and was detected in 63%, 13%, and 2%, respectively, of the 52 genital ulcer specimens. The corresponding figures in Mbeya were 34%, 10%, and 0% of 50 specimens. Overall, 9% of the 102 patients with GUD were infected with both HSV-2 and, and 39/102 genital ulcer specimens (38%) were negative for the DNA of all three pathogens. The HIV infection rates among GUD patients were 46% and 52% in Dar es Salaam and Mbeya, respectively; among the non-GUD patients, the corresponding rates were 35% and 45%, respectively. The HIV infection rate in Dar es Salaam was significantly higher among women (11/14; 78%) than among men (13/38; 34%) (P = 0.004). Among the HIV-seropositive GUD patients, 71% and 46% (P < 0.003) were coinfected with HSV-2 in Dar es Salaam and Mbeya, respectively. Furthermore, women with HSV-2 in Dar es Salaam were significantly more likely to be HIV-infected than men (60% versus 39%; P

Subject(s)
Genital Diseases, Female/etiology , Genital Diseases, Male/etiology , HIV Infections/complications , Ulcer/etiology , Urban Population , Adolescent , Adult , Antibodies, Bacterial/blood , Cross-Sectional Studies , Female , HIV Antibodies/blood , HIV Infections/virology , Haemophilus ducreyi/genetics , Haemophilus ducreyi/isolation & purification , Herpes Genitalis/etiology , Herpesvirus 2, Human/genetics , Herpesvirus 2, Human/isolation & purification , Humans , Male , Middle Aged , Polymerase Chain Reaction , Sexually Transmitted Diseases/etiology , Tanzania , Treponema pallidum/genetics , Treponema pallidum/immunology , Treponema pallidum/isolation & purification
9.
Microb Pathog ; 33(2): 49-62, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12202104

ABSTRACT

The cytolethal distending toxin of Haemophilus ducreyi (HdCDT) is a three-component toxin that induces the arrest of the mammalian cell cycle in the G2 phase. All of the individual gene products, CdtA, CdtB and CdtC, are required for toxic activity on cultured mammalian cells. The CdtB component alone exerts nuclease activity. The individual HdCDT components were purified by affinity chromatography or ion-exchange chromatography followed by gel-filtration. HdCDT was reconstituted and purified by the immobilization of a GST-CdtB fusion on a GSTrap column and the subsequent addition of cell sonicates from Escherichia coli recombinants that produced CdtA and CdtC. The purified HdCDT preparation contained all three CDT proteins, as detected by immuno-blotting, and had high cytotoxic activity (10(6)CPU/ml). Immunization of rabbits with the HdCDT complex and with the individual CdtA, CdtB and CdtC proteins elicited high titres of antibodies, as detected by ELISA. All of the immune sera had toxin-neutralizing activities. The pathological effects of the HdCDT complex were investigated in rabbits, since the proliferation of two rabbit cell lines, SIRC and RK-13, was inhibited by HdCDT. Intradermal injection of HdCDT (1, 10, 50 and 100microg protein) into naive rabbits resulted in dose-dependent skin reactions (erythema) about 24h after injection. Similar effects were not observed when the individual HdCDT proteins were injected. HdCDT injection into immune rabbits resulted in dose-dependent skin responses that were characterized by both erythema and oedema. Histological evaluation of the 24-h lesions in naive rabbits that were injected with HdCDT, revealed moderate levels of inflammatory cells, which were mainly granulocytes and macrophages, and dilatation of blood vessels. The skin reactions in HdCDT-injected immunized rabbits showed pronounced vascular changes and extensive infiltration of inflammatory cells, including eosinophils. All of the pathological changes healed after 3 days. In conclusion, purified HdCDT holotoxin is a complex of all three CDT proteins and all three components induce neutralizing antibodies when injected in rabbits. HdCDT causes dose-dependent pathologic skin reactions in both naive and immune rabbits, which is characterized by increased inflammatory responsiveness after each immunization.


Subject(s)
Bacterial Toxins/immunology , Bacterial Toxins/toxicity , Chancroid/prevention & control , Haemophilus ducreyi/pathogenicity , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Antibodies, Monoclonal/blood , Antibodies, Monoclonal/immunology , Bacterial Toxins/genetics , Bacterial Toxins/isolation & purification , Cell Line , Chancroid/microbiology , Chancroid/physiopathology , Cytotoxicity Tests, Immunologic , Disease Models, Animal , Haemophilus Vaccines/administration & dosage , Haemophilus Vaccines/immunology , Haemophilus ducreyi/genetics , Haemophilus ducreyi/immunology , Humans , Immunization , Mice , Mice, Inbred BALB C , Neutralization Tests , Rabbits , Skin/pathology
10.
Infect Immun ; 70(2): 899-908, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11796625

ABSTRACT

We investigated the phagocytosis of Haemophilus ducreyi both in vitro and in vivo. Human granulocyte and monocyte phagocytosis of opsonized and nonopsonized, fluorescence-labeled H. ducreyi was assessed by flow cytometry. Both Escherichia coli and noncapsulated H. influenzae were included as controls. The maximal percentage of granulocytes taken up by H. ducreyi was 35% after 90 min. In contrast, 95% of H. influenzae bacteria were phagocytosed by granulocytes after 30 min. These results indicated that H. ducreyi phagocytosis was slow and inefficient. Bacterial opsonization by using specific antibodies increased the percentage of granulocytes phagocytosing H. ducreyi from 24 to 49%. The nonphagocytosed bacteria were completely resistant to phagocytosis even when reexposed to granulocytes, indicating that the H. ducreyi culture comprised a mixture of phenotypes. The intracellular survival of H. ducreyi in granulocytes, in monocytes/macrophages, and in a monocyte cell line (THP-1) was quantified after application of gentamicin treatment to kill extracellular bacteria. H. ducreyi survival within phagocytes was poor; approximately 11 and <0.1% of the added bacteria survived intracellularly after 2 and 20 h of incubation, respectively, while no intracellular H. influenzae bacteria were recovered after 2 h of incubation with phagocytes. The role of phagocytes in the development of skin lesions due to H. ducreyi was also studied in vivo. Mice that were depleted of granulocytes and/or monocytes and SCID mice, which lacked T and B cells, were injected intradermally with approximately 10(6) CFU of H. ducreyi. Within 4 days of inoculation, the granulocyte-depleted mice developed lesions that persisted throughout the experimental period. This result reinforces the importance of granulocytes in the early innate defense against H. ducreyi infection. In conclusion, H. ducreyi is insufficiently phagocytosed to achieve complete eradication of the bacteria. Indeed, H. ducreyi has the ability to survive intracellularly for short periods within phagocytic cells in vitro. Since granulocytes play a major role in the innate defense against H. ducreyi infection in vivo, bacterial resistance to phagocytosis probably plays a crucial role in the pathogenesis of chancroid.


Subject(s)
Granulocytes/microbiology , Haemophilus ducreyi/immunology , Monocytes/microbiology , Phagocytosis/immunology , Animals , Cells, Cultured , Chancroid/immunology , Chancroid/microbiology , Chancroid/pathology , Disease Models, Animal , Female , Granulocytes/cytology , Granulocytes/immunology , Haemophilus ducreyi/growth & development , Humans , Injections, Intradermal , Mice , Mice, Inbred BALB C , Mice, SCID , Monocytes/cytology , Monocytes/immunology , Opsonin Proteins/immunology , Skin Ulcer/immunology , Skin Ulcer/microbiology , Skin Ulcer/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...